Detalhe da pesquisa
1.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021929
2.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657221
3.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779595
4.
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience.
Ann Hematol
; 102(1): 141-154, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367559
5.
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
Am J Hematol
; 98(3): 449-463, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594167
6.
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Br J Haematol
; 194(1): 145-157, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34124796
7.
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
; 126(23): 5077-5087, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965680
8.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871976
9.
To b(ortezomib) or not to be: the stroma's the thing.
J Pathol
; 240(2): 123-5, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27340009
10.
Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy.
Br J Haematol
; 171(1): 13-28, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018193
11.
Man versus Nature - Also Sprach Zarathustra and an End-of-Life House Call.
N Engl J Med
; 377(8): 709-711, 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834470
12.
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Leukemia
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750138
13.
The kelch protein KLHDC8B guards against mitotic errors, centrosomal amplification, and chromosomal instability.
J Biol Chem
; 287(46): 39083-93, 2012 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22988245
14.
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases.
Transplant Cell Ther
; 29(2): 125.e1-125.e9, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442768
15.
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 29(2): 123.e1-123.e10, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442769
16.
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
Blood Adv
; 7(22): 7007-7016, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792849
17.
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells.
Proc Natl Acad Sci U S A
; 106(35): 14920-5, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19706467
18.
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Transplant Cell Ther
; 28(10): 696.e1-696.e7, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798233
19.
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 28(6): 310-320, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314376
20.
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 28(4): 187.e1-187.e10, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081472